Bridging the Gap Between Innovation and Real-World Clinical Solutions
Our technology addresses one of the biggest challenges in regenerative medicine:
The Accessibility and Scalability of Tissue-specific Adult Stem Cells.
Our cutting-edge technology provides a scalable, efficient, and safe solution, bringing the promise of advanced stem cell therapies closer to reality for patients worldwide.
Backed by robust proof-of-concept data, our results demonstrate the potential to revolutionize treatment options for a range of human diseases, offering hope for safer, more effective, and scalable solutions.
With a focus on delivering impactful outcomes, we are poised to bring these innovative therapies closer to clinical reality.
With articular cartilage injuries affecting up to 36% of athletes and osteoarthritis impacting over 53 million adults in the U.S. alone, the demand for advanced, less invasive therapies is greater than ever.
Current regenerative approaches rely on invasive procedures using mesenchymal stem cells derived from bone marrow. While effective, these methods face limitations in terms of scalability, accessibility, and patient recovery.
Our innovative, IP-licensed method generate functional chondrocytes—specialized cartilage-producing cells—from readily skin somatic cells, eliminating the need for invasive bone marrow procedures.
This program offers a scalable, patient-friendly solution to meet the growing need for effective cartilage repair, representing a significant advancement in regenerative medicine and improving outcomes for millions of patients.
By offering a less invasive and highly scalable method to generate human keratinocyte stem cells, we aim to revolutionize skin wound repair therapies.
Chiron is setting a new standard in wound care, delivering solutions that promise better patient outcomes and greater accessibility for those in need of effective skin healing treatments.
We'd love to hear from you! Please fill out the form below to get in touch.